[ad_1] The logo of Swiss pharmaceutical group Lonza is seen at its headquarters in Basel, Switzerland March 2, 2020. REUTERS/Arnd Wiegmann (Reuters) – Moderna Inc and Swiss contract drugmaker Lonza…
Tag: Pharmaceuticals (TRBC level 4)
Swiss boost COVID-19 vaccine reservations with shots from Pfizer, WHO-led programme
[ad_1] FILE PHOTO: Small bottles labelled with “Vaccine” stickers stand near a medical syringe in front of displayed “Coronavirus COVID-19” words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File…
UPDATE 1-Italy ready to raise 2021 deficit to support businesses through Covid-19 – PM
[ad_1] (Adds quote, context) MILAN, Nov 11 (Reuters) – Italy’s government is ready to increase its 2021 budget deficit and review this year’s to fund further compensation for businesses hit…
Factbox: Moderna’s mRNA coronavirus vaccine
[ad_1] (Reuters) – Moderna Inc became the second U.S company to release full results from a large study of its experimental vaccine, saying it was 94.1% effective against COVID-19. FILE…
UPDATE 1-UK Stocks-Factors to watch on Jan 10
[ad_1] (Adds company news items and futures) Jan 10 (Reuters) – Britain’s FTSE 100 index is seen opening down 4 points on Wednesday, according to financial bookmakers, with futures down…
Swiss tighten measures to combat COVID-19 second wave
[ad_1] ZURICH (Reuters) – Switzerland announced tighter restrictions on Sunday to tackle the second wave of the coronavirus hitting the country, including a nation-wide obligation to wear masks and a…
Switzerland to start easing COVID-19 restrictions from April 27
[ad_1] ZURICH, April 16 (Reuters) – The Swiss government will start a gradual relaxation of restrictions brought in to tackle spread of the new coronavirus from April 27, it said…